К содержанию
Dr. Tara EinullaevaMedical oncologist

Side effects 10 min

Numbness in hands and feet during chemo: peripheral neuropathy

Which drugs cause numbness and tingling in the hands and feet, why you should tell your doctor about the first symptoms straight away, and what really helps.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 16 October 2026

Numbness, tingling or burning in your fingers and toes during chemotherapy is usually chemotherapy-induced peripheral neuropathy (damage to the peripheral nerves caused by cancer drugs). It is common, it depends on the specific drug and the total dose received, and the sooner you tell your doctor about it, the better the chance of avoiding lasting problems. Below I explain which drugs cause it, what it feels like, what actually helps and how to keep yourself safe at home.

Which drugs cause neuropathy

According to the Russian Society of Clinical Oncology (RUSSCO) guidelines, peripheral neuropathy develops in up to 40% of patients receiving chemotherapy. Three groups of drugs are the most damaging to nerves:

  • Platinum drugs — above all oxaliplatin and cisplatin.
  • Taxanes — paclitaxel, docetaxel.
  • Vinca alkaloids — vincristine, vinblastine, vinorelbine.

Besides these, neuropathy can be caused by bortezomib, which is used for multiple myeloma. Immunotherapy also occasionally affects the nerves, but through a different mechanism — more on that below.

The risk rises with the cumulative (total) dose: neuropathy usually appears not after the first treatment but after several cycles. That is why your doctor asks about symptoms before every treatment, even if everything was fine last time.

What it feels like

Most often the sensory nerves are affected. Symptoms start at the tips of the toes and fingers and may spread upwards in a “stocking and glove” pattern:

  • numbness, tingling, “pins and needles”;
  • burning or shooting pain;
  • a feeling of walking on cotton wool or wearing thick socks;
  • reduced sensitivity to heat, cold and pain — you may not notice a burn or a cut.

If the motor nerves are affected, there is weakness in the hands and feet, it becomes hard to do up buttons or open a jar, balance is lost and people trip. Less often the autonomic nerves are affected — then there may be constipation, dizziness on standing up, and problems passing urine.

A special case — oxaliplatin and cold

Oxaliplatin has an acute form of nerve toxicity that differs from ordinary neuropathy. During the infusion and in the days after it, cold triggers unpleasant sensations in the hands, face and mouth: tingling, burning, a spasm when swallowing something cold. This usually lasts 2–4 days after the drip. Patients on oxaliplatin often ask me whether this is dangerous. In itself, no — but on those days I advise not drinking cold drinks, not taking things out of the freezer with bare hands and covering your mouth and nose with a scarf in cold weather. And be sure to tell your doctor: how severe the acute symptoms are is linked to the risk of developing lasting neuropathy later.

Why you should report the first symptoms straight away

Many people put up with it for as long as they can, afraid that “the treatment will be stopped”. But neuropathy has an unpleasant feature — it builds up, and if it is missed, the damage can stay for a long time.

Your doctor assesses the grade of neuropathy before each treatment. The approach in the RUSSCO guidelines is this: at grade 1 (put simply, mild symptoms that don’t interfere with daily life) treatment continues unchanged; at grade 2 (symptoms interfere with more complex everyday tasks) a dose reduction of 25–50% is discussed; at grade 3 and above the drug is delayed or stopped.

ASCO experts describe this as weighing benefit against harm: if, for example, significant neuropathy appears after the 8th of 12 planned cycles, the doctor assesses how much the remaining treatments will add compared with the risk of lasting nerve damage. Sometimes the drug causing the neuropathy is simply dropped from the regimen and the others are continued.

Don’t wait for your next scheduled appointment if the numbness is getting worse from one treatment to the next, if it has become hard to do up buttons or hold a pen, or if you have started tripping. Talk to your oncologist before the next infusion.

What to note down for your appointment: exactly where it is numb, when it started, whether it makes it harder to do up buttons, write, walk, or keep your balance in the dark. Specific observations like these help assess the grade more accurately.

What helps — and what doesn’t

I’ll be honest: there is no universal remedy for chemotherapy-induced neuropathy. Here is what the ASCO guidelines (2020 update) and the RUSSCO guidelines say.

What we know
Preventive drugs No agent has been shown to prevent neuropathy. ASCO does not recommend any preventive drugs; acetyl-L-carnitine may even be harmful
Cooling, compression, physical activity There are encouraging but not yet convincing data; they are used, and no harm is expected for most patients
Duloxetine The only drug ASCO recommends for treating painful neuropathy. In a trial, 59% of patients on duloxetine reported less pain versus 38% on placebo
Other drugs for nerve pain Pregabalin, gabapentin, tricyclic antidepressants — the evidence is limited; they are tried in selected patients after discussing benefits and risks
Non-drug approaches Exercise therapy, acupuncture — unproven but reasonable options

Duloxetine is an antidepressant, but in neuropathy it is prescribed not for mood but because it reduces nerve pain specifically. It doesn’t help everyone, and it targets pain and burning rather than numbness as such. Your doctor chooses it taking your other medicines into account: duloxetine interacts with some drugs.

B vitamins, alpha-lipoic acid and other “nerve-protecting” agents are often prescribed. If you have been given them, discuss them with your oncologist, but don’t count on them preventing neuropathy: there is no convincing evidence for that. And don’t start anything on your own: some supplements interact with chemotherapy drugs.

Staying safe at home

When your fingers and toes can’t feel properly, everyday details become risky. The US National Cancer Institute (NCI) recommendations are fairly simple:

  • Preventing falls. Move rugs out of the way, fit grab rails in the bathroom, use a non-slip mat in the shower. Get up slowly, especially if you feel dizzy. Leave a light on in the hallway at night.
  • Shoes. Wear sturdy shoes with soft soles both indoors and outdoors. Don’t walk barefoot.
  • Hot water. Have someone check the water temperature or use a thermometer — numb fingers won’t feel a burn. Fit a temperature limiter on your water heater if you can.
  • Kitchen. Use oven gloves and handle knives carefully.
  • Checking. Look at your feet and hands every day for cuts, blisters or redness.
  • Cold. Dress warmly in winter, especially during treatment with oxaliplatin.

And don’t hesitate to accept help where things are hard right now, and give yourself more time for familiar tasks.

Why it can get worse after treatment ends

This frightens patients more than anything: chemotherapy is over, yet the numbness keeps getting worse. With platinum drugs — cisplatin and oxaliplatin — this does happen: symptoms can intensify for several months after the last treatment. This is called “coasting”. It doesn’t mean the disease has come back or that the damage will keep growing indefinitely — it is a feature of how the drug acts on nerve cells. But you should still tell your doctor about it.

Will sensation come back

The outlook depends on the drug, the total dose and how severe the neuropathy was.

In a meta-analysis of 31 studies (4,179 patients), neuropathy was present in 68% of patients in the first month after chemotherapy, in 60% at 3 months and in about 30% at 6 months or later. So for many people symptoms ease, but for some they last a long time. The European ESMO guidelines state plainly that recovery is more often partial.

Neuropathy caused by taxanes may partly reverse after the drug is stopped; neuropathy from bortezomib is usually reversible. After platinum drugs, recovery is slower. Time, physical activity and working with a rehabilitation specialist help you adapt, even if sensation hasn’t fully returned.

A note on immunotherapy

With immunotherapy, nerve damage is rare but can develop quickly — similar to Guillain–Barré syndrome, with increasing weakness in the legs. If, while on immunotherapy, you develop leg weakness over a few days, find it hard to climb stairs, or numbness is quickly spreading upwards — call your doctor the same day. If you have difficulty breathing or swallowing, call your local emergency number (911 in the US, 999 in the UK, 112 in the EU).

Questions to ask your oncologist

  • Does my regimen include drugs that cause neuropathy?
  • Which symptoms should I watch for, and which should I report straight away?
  • What happens if the neuropathy gets worse — will the dose be reduced or the drug dropped?
  • Do I need to take any precautions with cold (if oxaliplatin is in my regimen)?
  • Would it make sense to see a neurologist or a rehabilitation specialist?

For more on how cycles work and what happens on treatment day, see the article on what chemotherapy is like. If numbness is affecting your life and you’re not sure whether to continue the regimen as it is, I can review your situation in an online consultation — with a written summary and a list of questions for your oncologist.

Sources

  1. Neurological complications of anticancer drug therapy. RUSSCO practical guidelines — Russian Society of Clinical Oncology (RUSSCO), 2023
  2. Updated ASCO Guideline Revisits Evidence on Prevention and Treatment of Chemotherapy-Induced Neuropathy — The ASCO Post, 2020
  3. Nerve Problems (Peripheral Neuropathy) and Cancer Treatment — National Cancer Institute (NCI), accessed 2026
  4. Chemotherapy-Induced Peripheral Neuropathy: A Current Review — Staff N. P. et al., Annals of Neurology, 2017
  5. Incidence, prevalence and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis — Seretny M. et al., Pain, 2014
  6. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines — ESMO / EONS / EANO, 2020

Frequently asked questions

This article is for information only and does not replace a consultation with your treating doctor. Decisions about tests and treatment are made by the doctor who looks after you.